Dr Rob Commons is an Infectious Diseases Physician completing the stages of his PhD with Professor Ric Price through Menzies School of Health Research in Darwin. He is co-supervised by Prof Julie Simpson from the Centre for Epidemiology and Biostatistics at the University of Melbourne. His current research focuses on identifying improvements in the treatment of P. vivax using a combination data from retrospective and prospective clinical studies. Affiliated with the WorldWide Antimalarial Resistance Network (WWARN) he is undertaking large scale individual patient pooled analyses to investigate the dose effect of schizontocidal drugs on vivax recurrence and the impact of primaquine on recurrence and the haematological response. In addition, using data from large multicenter prospective studies he is assessing the cumulative risk of anaemia with repeat vivax infections.